Cooper Companies (The)COOEarnings & Financial Report
The Cooper Companies, Inc., branded as CooperCompanies, is a global medical device company headquartered in San Ramon, California. The company consists of two business units, CooperVision (CVI) which manufactures contact lenses, and CooperSurgical (CSI), which manufactures medical devices and fertility and genomic products for the women's healthcare market.
Revenue
$964.7M
Gross Profit
$660.2M
Operating Profit
$182.0M
Net Profit
$104.3M
Gross Margin
68.4%
Operating Margin
18.9%
Net Margin
10.8%
YoY Growth
3.6%
EPS
$0.52
Cooper Companies (The) Q1 FY2025 Financial Summary
Cooper Companies (The) reported revenue of $964.7M (up 3.6% YoY) for Q1 FY2025, with a net profit of $104.3M (up 28.4% YoY) (10.8% margin). Cost of goods sold was $304.5M, operating expenses totaled $478.2M.
Key Financial Metrics
| Total Revenue | $964.7M |
|---|---|
| Net Profit | $104.3M |
| Gross Margin | 68.4% |
| Operating Margin | 18.9% |
| Report Period | Q1 FY2025 |
Revenue Breakdown
Cooper Companies (The) Q1 FY2025 revenue of $964.7M breaks down across 3 segments, led by Coopervision Segment at $646.1M (67.0% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Coopervision Segment | $646.1M | 67.0% |
| Office And Surgical | $198.9M | 20.6% |
| Fertility | $119.7M | 12.4% |
Cooper Companies (The) Revenue by Segment — Quarterly Trend
Cooper Companies (The) revenue by segment across the last 4 reported quarters, showing how each business line (such as Coopervision Segment and Office And Surgical) has evolved quarter over quarter.
| Segment | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 |
|---|---|---|---|---|
| Coopervision Segment | — | — | — | $646.1M |
| Office And Surgical | $214.5M | $204.8M | $205.8M | $198.9M |
| Fertility | $140.9M | $137.1M | $126.9M | $119.7M |
Cooper Companies (The) Annual Revenue by Year
Cooper Companies (The) annual revenue history includes year-by-year totals (for example, 2025 revenue was $4.1B).
| Year | Annual Revenue |
|---|---|
| 2025 | $4.1B |
| 2024 | $3.9B |
| 2023 | $3.6B |
| 2022 | $3.3B |
Cooper Companies (The) Quarterly Revenue & Net Profit History
Cooper Companies (The) results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $1.1B | +4.6% | $84.6M | 7.9% |
| Q3 FY2025 | $1.1B | +5.7% | $98.3M | 9.3% |
| Q2 FY2025 | $1.0B | +6.3% | $87.7M | 8.7% |
| Q1 FY2025 | $964.7M | +3.6% | $104.3M | 10.8% |
| Q4 FY2024 | $1.0B | +9.8% | $117.5M | 11.5% |
| Q3 FY2024 | $1.0B | +7.8% | $104.7M | 10.4% |
| Q2 FY2024 | $942.6M | +7.4% | $88.9M | 9.4% |
| Q1 FY2024 | $931.6M | +8.5% | $81.2M | 8.7% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $931.6M | $942.6M | $1.00B | $1.02B | $964.7M | $1.00B | $1.06B | $1.07B |
| YoY Growth | 8.5% | 7.4% | 7.8% | 9.8% | 3.6% | 6.3% | 5.7% | 4.6% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $12.03B | $12.05B | $12.11B | $12.32B | $12.22B | $12.41B | $12.38B | $12.39B |
| Liabilities | $4.34B | $4.24B | $4.18B | $4.23B | $4.09B | $4.13B | $4.02B | $4.16B |
| Equity | $7.70B | $7.80B | $7.92B | $8.08B | $8.13B | $8.29B | $8.35B | $8.24B |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $122.7M | $111.0M | $207.5M | $268.1M | $190.6M | $96.2M | $261.4M | $247.9M |